Signal transducer and activator of transcription proteins in leukemias
- 15 April 2003
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 101 (8) , 2940-2954
- https://doi.org/10.1182/blood-2002-04-1204
Abstract
Signal transducer and activator of transcription (STAT) proteins are a 7-member family of cytoplasmic transcription factors that contribute to signal transduction by cytokines, hormones, and growth factors. STAT proteins control fundamental cellular processes, including survival, proliferation, and differentiation. Given the critical roles of STAT proteins, it was hypothesized that inappropriate or aberrant activation of STATs might contribute to cellular transformation and, in particular, leukemogenesis. Constitutive activation of mutated STAT3 has in fact been demonstrated to result in transformation. STAT activation has been extensively studied in leukemias, and mechanisms of STAT activation and the potential role of STAT signaling in leukemogenesis are the focus of this review. A better understanding of mechanisms of dysregulation of STAT signaling pathways may serve as a basis for designing novel therapeutic strategies that target these pathways in leukemia cells.Keywords
This publication has 255 references indexed in Scilit:
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cellsOncogene, 2000
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- STAT signaling in the pathogenesis and treatment of leukemiasOncogene, 2000
- Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in miceOncogene, 2000
- STATs in oncogenesisOncogene, 2000
- The Jak-STAT pathwayMolecular Immunology, 2000
- IL-6 up-regulates Mcl-1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathwayEuropean Journal of Immunology, 1999
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT PathwayAnnual Review of Biochemistry, 1995